Medtech Deals Rise: Cardiovascular & Robotics Lead
According to a recent PitchBook report, MedTech M&A is on the rise, especially with cardiovascular tech and surgical robotics.
Key points to note about this recent shift:
▪️ Q1 2024 saw $3.3B in funding, up from $2.8B in Q4 2023
▪️ and surgical robotics led the charge with $2.2B and $1B, respectively, in the past year
▪️ About 1/2 of the Q1 funding went to later-stage deals. This surge in deal value suggests there could be a strong rest of the year ahead for Manda activity.
Stabilizing public medtech valuations could further contribute to this trend, allowing for new opportunities for growth and innovation.
Read the full here https://www.axios.com/pro/health-tech...
Follow me, Louis Lehot, for more business insights, and read our full article here https://www.axios.com/pro/health-tech...
Discover more about Louis Lehot and explore additional professional insights on his website: https://louislehot.com
Explore more of Louis Lehot’s insightful articles at / lehotlouis . Know more about Louis here:
Louis Lehot Substack: https://louislehotattorney.substack.com/
Louis Lehot Chambers: https://chambers.com/lawyer/louis-leh...
Louis Lehot Superlawyers:https://profiles.superlawyers.com/cal...